PlexusDx tracks multiple clinical markersweight, metabolic bloodwork, and symptom patternsto confirm your medication is working regardless of urination frequency
Following a thorough analysis of our previous Phase 2b data and trial design, we believe that with the preferred modified release formulation and future trial design optimization, we can advance a competitive oral GLP-1 molecule into registration enabling studies, with the goal of addressing the present and persistent medical needs of people living with obesity. The ongoing open-label, randomized study is evaluating the pharmacokinetics and safety of immediate- and modified release formulations of danuglipron administered orally in healthy adults 18 years or older
We encourage you to continue visiting us for weight management
Important Information About Drug Interactions Just like injectable semaglutide, our oral options can interact with certain medications
SPEAKER 4: I have been on Ozempic for four or five months
We have helped thousands of people in Colorado, Wyoming, New Jersey, Pennsylvania, Texas, Wisconsin restore their health and quality of life by diagnosing and treating their Lyme Disease